Oral Cavity Cancer: Causes, Symptoms, Diagnosis and Treatment — Overview, Diagnosis & Treatment Options | MyMedicPlus

Oral cavity cancer arises from the squamous epithelium or minor salivary glands lining the lips, anterior tongue, gums, floor of mouth, hard palate, retromolar trigone, and buccal mucosa. Globally, approximately 354,000 new cases of lip and oral cavity cancer are diagnosed each year, accounting for roughly 2% of all malignancies. Squamous cell carcinoma (SCC) represents over 90% of cases. The disease disproportionately affects adults aged 50 and older, with a higher incidence in men, though incidence in younger women is rising in some populations. Oral cavity SCC is distinctly different from oropharyngeal SCC in etiology, biology, and treatment approach — it is predominantly tobacco- and alcohol-driven rather than HPV-driven, and surgery rather than chemoradiation is the primary treatment modality. Early-stage detection carries an excellent prognosis, but over half of patients present with locally advanced disease.

Tobacco use in any form — cigarette smoking, cigar and pipe smoking, and smokeless tobacco including chewing tobacco and snuff — is the primary carcinogen. Heavy alcohol consumption acts synergistically with tobacco, increasing oral cavity SCC risk by up to 35-fold when both exposures are combined. Together, tobacco and alcohol are responsible for approximately 75% of oral cavity cancers in developed nations. Betel quid chewing, widely practiced in South and Southeast Asia, is a major risk factor for oral submucous fibrosis and SCC in these populations. Poor oral hygiene, ill-fitting dentures causing chronic mucosal irritation, and nutritional deficiencies (vitamins A and C) are contributing factors. Chronic sun exposure causes lip cancer specifically, particularly the lower lip. Pre-malignant lesions — leukoplakia (white patches) and erythroplakia (red patches, higher malignant potential) — are recognized precursor conditions that require biopsy and close follow-up.

Early oral cavity cancers are often asymptomatic or cause only mild discomfort, which frequently delays presentation. Key warning signs include a persistent non-healing ulcer or sore in the mouth lasting more than two weeks; a white or red patch (leukoplakia or erythroplakia) on the gums, tongue, or inner cheek; a palpable lump or thickening within the oral soft tissues; unexplained pain or numbness in the mouth or lips; difficulty or pain on chewing, swallowing, or moving the tongue or jaw; loosening of teeth without dental disease; persistent halitosis; and a chronic sore throat without obvious infection. Jaw swelling or trismus (inability to open the mouth fully) suggest invasion of the mandible or pterygoid musculature. Ipsilateral neck mass indicates cervical lymph node metastasis, present in approximately 40% at diagnosis.

Punch or incisional biopsy of any suspicious oral mucosal lesion is the cornerstone of diagnosis. Panendoscopy (laryngoscopy, esophagoscopy, bronchoscopy) detects synchronous primary tumors of the upper aerodigestive tract, which occur in 2-4% of patients. CT of the head and neck with contrast defines primary tumor extent, cortical bone invasion of the mandible or maxilla, and cervical nodal involvement. MRI provides superior soft tissue delineation for tongue base and floor of mouth tumors. Dental panoramic X-ray (OPG) assesses mandibular involvement. PET/CT evaluates regional and distant metastatic disease. AJCC 8th edition TNM staging is applied; T staging considers tumor size and depth of invasion (DOI), which is a critical independent predictor of nodal metastasis risk. HPV/p16 testing is standard practice to distinguish oropharyngeal from oral cavity primaries.

Surgery is the preferred primary modality for most resectable oral cavity cancers. Wide local excision with tumor-free margins of at least 5 mm is the goal, combined with ipsilateral or bilateral neck dissection (selective or comprehensive depending on clinical and imaging nodal status). Free flap reconstruction — commonly radial forearm or fibula flaps — restores form and function after major resections. Adjuvant postoperative radiotherapy (60-66 Gy over 6 weeks) is indicated for high-risk pathological features including positive or close margins, multiple positive lymph nodes, extranodal extension (ENE), perineural invasion, or lymphovascular invasion. Concurrent cisplatin chemotherapy (100 mg/m² every 3 weeks or weekly dosing) is added to adjuvant radiation for patients with positive margins or extranodal extension per RTOG 9501 and EORTC 22931 trial evidence. Cetuximab (anti-EGFR) is used for platinum-ineligible patients. Pembrolizumab or nivolumab are approved for recurrent/metastatic disease after platinum failure.

Complete tobacco cessation — whether cigarettes, smokeless tobacco, or betel quid — is the single most impactful preventive measure and reduces risk even in long-term users. Alcohol consumption should be limited to established guidelines or eliminated entirely. Regular dental examinations (every 6-12 months) provide opportunity for visual oral mucosal screening, enabling identification of leukoplakia, erythroplakia, and early asymptomatic lesions. Patients with known premalignant lesions require close surveillance with repeat biopsy when lesion characteristics change. Adequate dietary intake of fruits and vegetables rich in antioxidant vitamins may provide modest protective benefit. Protection from sun exposure to the lips (UV-blocking lip balm) reduces lip cancer risk. Oral health maintenance and prompt treatment of ill-fitting dentures remove chronic mechanical mucosal irritation.

Any mouth sore or ulcer that fails to heal within two weeks — even if painless — requires urgent dental or medical evaluation and biopsy referral. White or red patches inside the mouth that are new, enlarging, or changing in character should be evaluated by an oral surgeon or ENT specialist without delay. Unexplained persistent pain, numbness, or burning in the mouth, particularly in a patient who smokes or uses tobacco in any form, warrants prompt specialist review. A new painless neck lump in a patient with oral symptoms should be assessed urgently, as it may represent lymph node metastasis. Tobacco users and heavy drinkers — particularly those over age 40 — are strongly encouraged to undergo annual oral mucosal examination as part of routine healthcare. Any difficulty opening the jaw, persistent earache without ear disease, or unexplained trismus must be investigated without delay.

Stage I/II disease: 5-year survival 70-90%. Stage III/IV: 20-40%. HPV-negative oral cavity tumors carry a worse prognosis than HPV-positive oropharyngeal cancers. Depth of invasion and extranodal extension are key prognostic determinants. Early detection and treatment at specialized head and neck oncology centers significantly improves outcomes. The prognosis for Oral Cavity Cancer: Causes, Symptoms, Diagnosis and Treatment varies depending on severity at diagnosis, the patient's overall health, and how promptly treatment is initiated. With early diagnosis and appropriate management, many patients achieve good outcomes and maintain quality of life. Regular follow-up with healthcare providers is essential to monitor progress, adjust treatment as needed, and detect any complications early. Adherence to prescribed treatments and lifestyle modifications significantly improves long-term prognosis.